Chatterjee Shubhangini, Rajasekar Arvina
Periodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.
Cureus. 2024 May 18;16(5):e60534. doi: 10.7759/cureus.60534. eCollection 2024 May.
Introduction Periodontitis, a persistent inflammatory condition, impacts the tissues supporting teeth. Beyond mechanically eradicating the biofilm, additional host-modulating agents can aid in the treatment of periodontitis. Among these, gels are a very popular choice for use in the field of dentistry as these systems boast high biocompatibility and bioadhesiveness. These qualities make them easily administered and fabricated. They are typically placed into the periodontal site via wide-port needle syringes. Many investigations have demonstrated that hydrogels possess the ability for controlled drug release and aid in periodontal wound healing. Hence, this study aimed to develop a ferulic acid hydrogel and assess its effectiveness for managing periodontitis. Materials and methods Ferulic acid hydrogel was prepared followed by haemolysis assay and biocompatibility assay. After the in vitro analysis, a clinical trial was conducted: 20 patients were divided into Group A (comprising patients in whom scaling and root planing (SRP) was done) and Group B (comprising patients in whom SRP along with hydrogel application was done). Each patient's pocket depth (PD), clinical attachment loss (CAL), gingival index (GI), and plaque index (PI) were recorded at baseline and at three months. Intergroup and intragroup comparisons of the parameters were made. Results Ferulic acid hydrogels exhibit a minimal ratio of red blood cell destruction, indicating their low haemolytic activity. Beyond 94 hours, ferulic acid hydrogel demonstrates minimal toxicity towards human fibroblasts, suggesting it has good biocompatibility. When clinical parameters were compared after three months of treatment with SRP alone, significant reductions were observed in all parameters. However, when hydrogel application was done along with SRP, greater reduction was seen in terms of all clinical parameters indicating the efficacy of the ferulic acid hydrogel as an adjunct. Conclusion Ferulic acid has distinct haemolytic activity as well as good biocompatibility. Its use also led to a considerable reduction in all clinical parameters, necessitating its role as a local drug delivery agent in the treatment of periodontitis.
引言
牙周炎是一种持续性炎症疾病,会影响牙齿的支持组织。除了机械清除生物膜外,其他宿主调节剂有助于牙周炎的治疗。其中,凝胶在牙科领域是非常受欢迎的选择,因为这些体系具有高生物相容性和生物粘附性。这些特性使它们易于给药和制备。它们通常通过宽口针筒注射器放置到牙周部位。许多研究表明,水凝胶具有控释药物的能力,并有助于牙周伤口愈合。因此,本研究旨在开发一种阿魏酸水凝胶,并评估其治疗牙周炎的有效性。
材料和方法
制备阿魏酸水凝胶,随后进行溶血试验和生物相容性试验。体外分析后,进行了一项临床试验:20名患者被分为A组(包括进行了龈下刮治和根面平整(SRP)的患者)和B组(包括进行了SRP并应用水凝胶的患者)。在基线和三个月时记录每位患者的牙周袋深度(PD)、临床附着丧失(CAL)、牙龈指数(GI)和菌斑指数(PI)。对这些参数进行组间和组内比较。
结果
阿魏酸水凝胶显示出极低的红细胞破坏率,表明其溶血活性低。超过94小时后,阿魏酸水凝胶对人成纤维细胞显示出极低的毒性,表明它具有良好的生物相容性。单独用SRP治疗三个月后比较临床参数时,所有参数均有显著降低。然而,当与SRP一起应用水凝胶时,所有临床参数均有更大程度的降低,表明阿魏酸水凝胶作为辅助药物的有效性。
结论
阿魏酸具有明显的溶血活性以及良好的生物相容性。其使用还导致所有临床参数大幅降低,使其有必要作为局部给药制剂用于牙周炎的治疗。